The University of Helsinki is one of the world’s leading multidisciplinary research universities, renowned for its high-quality teaching, research and innovation. The university is an international scientific community of 40,000 students and researchers. It is proud to be constantly ranked among the top one hundred best universities in the world. Through the power of science, the University has contributed to society, education and welfare since 1640.

The Institute for Molecular Medicine Finland (FIMM) is an international research unit focusing on human genomics and personalised medicine at the Helsinki Institute of Life Science (HiLIFE) of the University of Helsinki – a leading Nordic university with a strong commitment to life science research. FIMM integrates molecular medicine research and technology center and biobanking infrastructures under one roof promoting translational research in grand challenge projects. FIMM is the leading genomics research and bioinformatics unit in Finland. We manage petabytes of human genomic and health data and collaborate internationally with researchers, research institutes, pharmaceutical companies, and healthcare providers to improve health and well-being on a global scale. As part of Academic Medical Center Helsinki in Meilahti campus FIMM collaborates locally with the Faculty of Medicine, Helsinki University Hospital and National Institute for Health and Welfare. FIMM is part of the Nordic EMBL Partnership for Molecular Medicine, composed of the European Molecular Biology Laboratory (EMBL) and the centres for molecular medicine in Norway, Sweden and Denmark, and the EU-LIFE Community.

UNIVERSITY OF HELSINKI

INSTITUTE FOR MOLECULAR MEDICINE FINLAND (FIMM)
INSTITUTE OF SCIENCE (HiLIFE)

ACADEMIC MEDICAL CENTER HELSINKI IN MEILAHTI CAMPUS

UNIVERSITY OF HELSINKI

INSTITUTE FOR MOLECULAR MEDICINE FINLAND (FIMM)
INSTITUTE OF SCIENCE (HiLIFE)

ACADEMIC MEDICAL CENTER HELSINKI IN MEILAHTI CAMPUS

HELSINKI UNIVERSITY HOSPITAL

NATIONAL INSTITUTE FOR HEALTH AND WELFARE

NORDIC EMBL PARTNERSHIP FOR MOLECULAR MEDICINE

NEMHESYS – NGS Establishment in Multidisciplinary Healthcare Education System

  

The European Commission's support for the production of this website does not constitute an endorsement of the contents, which reflect the views only of the authors, and the Commission cannot be held responsible for any use which may be made of the information contained therein